Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
April 19, 2019
A Double-Blind, Placebo-Controlled, Phase 3b Study of ATX-101 for Reduction of Mild or Extreme Submental Fat
Richard G Glogau, Dee Anna Glaser, Valerie D Callender, et al.
Journal of Drugs in Dermatology : JDD
|
October 7, 2020
IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines
Martina Kerscher, Sabrina Fabi, Tanja Fischer, et al.
Journal of Drugs in Dermatology : JDD
|
October 12, 2021
IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines
Martina Kerscher, Sabrina Fabi, Tanja Fischer, et al.
Journal of the American Academy of Dermatology
|
December 4, 2019
DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)
Vince Bertucci, Nowell Solish, Joely Kaufman-Janette, et al.
Plastic and Reconstructive Surgery. Global Open
|
July 15, 2021
Best Clinical Practices with ATX-101 for Submental Fat Reduction: Patient-related Factors and Physician Considerations
Craig F Teller, Annie Chiu, Cameron D Chesnut, et al.
Aesthetic Surgery Journal
|
June 22, 2023
Efficacy and Safety of Tapencarium (RZL-012) in Submental Fat Reduction
Sachin M Shridharani, Steven Dayan, Brian Biesman, et al.
Aesthetic Surgery Journal
|
July 4, 2026
Treatment Satisfaction, Improvements in Jawline Definition, and Psychosocial Impact With OnabotulinumtoxinA for Platysma Prominence: Patient-Reported Outcomes From 2 Multicenter, Randomized, Placebo-Controlled Phase 3 Studies
Patricia Ogilvie, William P Coleman, Steven Dayan, et al.
Plastic and Reconstructive Surgery
|
October 7, 2015
Lower Face: Clinical Anatomy and Regional Approaches with Injectable Fillers
André Braz, Shannon Humphrey, Susan Weinkle, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
April 19, 2019
A Double-Blind, Placebo-Controlled, Phase 3b Study of ATX-101 for Reduction of Mild or Extreme Submental Fat
Richard G Glogau, Dee Anna Glaser, Valerie D Callender, et al.
Journal of Drugs in Dermatology : JDD
|
October 7, 2020
IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines
Martina Kerscher, Sabrina Fabi, Tanja Fischer, et al.
Journal of Drugs in Dermatology : JDD
|
October 12, 2021
IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines
Martina Kerscher, Sabrina Fabi, Tanja Fischer, et al.
Journal of the American Academy of Dermatology
|
December 4, 2019
DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)
Vince Bertucci, Nowell Solish, Joely Kaufman-Janette, et al.
Plastic and Reconstructive Surgery. Global Open
|
July 15, 2021
Best Clinical Practices with ATX-101 for Submental Fat Reduction: Patient-related Factors and Physician Considerations
Craig F Teller, Annie Chiu, Cameron D Chesnut, et al.
Aesthetic Surgery Journal
|
June 22, 2023
Efficacy and Safety of Tapencarium (RZL-012) in Submental Fat Reduction
Sachin M Shridharani, Steven Dayan, Brian Biesman, et al.
Aesthetic Surgery Journal
|
July 4, 2026
Treatment Satisfaction, Improvements in Jawline Definition, and Psychosocial Impact With OnabotulinumtoxinA for Platysma Prominence: Patient-Reported Outcomes From 2 Multicenter, Randomized, Placebo-Controlled Phase 3 Studies
Patricia Ogilvie, William P Coleman, Steven Dayan, et al.
Plastic and Reconstructive Surgery
|
October 7, 2015
Lower Face: Clinical Anatomy and Regional Approaches with Injectable Fillers
André Braz, Shannon Humphrey, Susan Weinkle, et al.
Page
of 2